LLYEli Lilly and CompanySigning up patients
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Neoplasms · Child · Adolescent
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 2
- Patients
- 105 (planned)
- Started
- Jan 22, 2020
- Main results expected
- May 2027
- Fully finished
- May 2027
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Number of Participants Allocated to Each ISA
Measured over: Baseline up to Week 4
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT05999994 · record last updated 2026-08-07 · checked 2026-11-09 15:36 UTC